| Neuroendocrine differentiation of prostate cancer leads to PSMA suppression MK Bakht, I Derecichei, Y Li, RM Ferraiuolo, M Dunning, SW Oh, ... Endocrine-related cancer 26 (2), 131-146, 2019 | 116 | 2019 |
| Differential expression of glucose transporters and hexokinases in prostate cancer with a neuroendocrine gene signature: a mechanistic perspective for 18F-FDG imaging of PSMA … MK Bakht, JM Lovnicki, J Tubman, KF Stringer, J Chiaramonte, ... Journal of Nuclear Medicine 61 (6), 904-910, 2020 | 65 | 2020 |
| Influence of androgen deprivation therapy on the uptake of PSMA-targeted agents: emerging opportunities and challenges MK Bakht, SW Oh, H Youn, GJ Cheon, C Kwak, KW Kang Nuclear Medicine and Molecular Imaging 51 (3), 202-211, 2017 | 58 | 2017 |
| Temporal evolution of cellular heterogeneity during the progression to advanced AR-negative prostate cancer NJ Brady, AM Bagadion, R Singh, V Conteduca, L Van Emmenis, E Arceci, ... Nature communications 12 (1), 3372, 2021 | 53 | 2021 |
| Scope of nanotechnology-based radiation therapy and thermotherapy methods in cancer treatment M K Bakht, M Sadeghi, M Pourbaghi-Masouleh, C Tenreiro Current cancer drug targets 12 (8), 998-1015, 2012 | 41 | 2012 |
| Internal radiotherapy techniques using radiolanthanide praseodymium-142: a review of production routes, brachytherapy, unsealed source therapy MK Bakht, M Sadeghi Annals of nuclear medicine 25, 529-535, 2011 | 36 | 2011 |
| A novel technique for simultaneous diagnosis and radioprotection by radioactive cerium oxide nanoparticles: study of cyclotron production of 137mCe MK Bakht, M Sadeghi, C Tenreiro Journal of Radioanalytical and Nuclear Chemistry 292 (1), 53-59, 2012 | 31 | 2012 |
| Preparation of radioactive praseodymium oxide as a multifunctional agent in nuclear medicine: expanding the horizons of cancer therapy using nanosized neodymium oxide MK Bakht, M Sadeghi, SJ Ahmadi, SS Sadjadi, C Tenreiro Nuclear Medicine Communications 34 (1), 5-12, 2013 | 29 | 2013 |
| Landscape of prostate-specific membrane antigen heterogeneity and regulation in AR-positive and AR-negative metastatic prostate cancer MK Bakht, Y Yamada, SY Ku, VB Venkadakrishnan, JA Korsen, ... Nature cancer 4 (5), 699-715, 2023 | 28 | 2023 |
| Practicality of the cyclotron production of radiolanthanide 142 Pr: a potential for therapeutic applications and biodistribution studies M Sadeghi, M Bakht, L Mokhtari Journal of Radioanalytical and Nuclear Chemistry 288 (3), 937-942, 2011 | 28 | 2011 |
| Taxane-induced attenuation of the CXCR2/BCL-2 axis sensitizes prostate cancer to platinum-based treatment VR de Porras, XC Wang, L Palomero, M Marin-Aguilera, C Solé-Blanch, ... European urology 79 (6), 722-733, 2021 | 19 | 2021 |
| Calcium phosphate nanoparticles cytocompatibility versus cytotoxicity: a serendipitous paradox MP Masouleh, V Hosseini, M Pourhaghgouy, MK Bakht Current pharmaceutical design 23 (20), 2930-2951, 2017 | 18 | 2017 |
| Production of cationic 198 Au 3+ and nonionic 198 Au 0 for radionuclide therapy applications via the nat Au (n, γ) 198 Au reaction M Sadeghi, H Jabal-Ameli, S Ahmadi, S Sadjadi, M Bakht Journal of Radioanalytical and Nuclear Chemistry 293 (1), 45-49, 2012 | 17 | 2012 |
| Identification of alternative protein targets of glutamate-ureido-lysine associated with PSMA tracer uptake in prostate cancer cells MK Bakht, JJ Hayward, F Shahbazi-Raz, M Skubal, R Tamura, KF Stringer, ... Proceedings of the National Academy of Sciences 119 (4), e2025710119, 2022 | 15 | 2022 |
| Overview of mercury radionuclides and nuclear model calculations of 195 Hg m, g and 197 Hg m, g to evaluate experimental cross section data M Sadeghi, M Bakhtiari, MK Bakht, M Anjomrouz, L Mokhtari Physical Review C 85 (3), 034605, 2012 | 14 | 2012 |
| Radiolabeled nanoceria probes may reduce oxidative damages and risk of cancer: A hypothesis for radioisotope-based imaging procedures MK Bakht, V Hosseini, H Honarpisheh Medical Hypotheses 81 (6), 1164-1168, 2013 | 9 | 2013 |
| Nuclear model calculations of charged-particle-induced reaction cross section data for the production of the radiohalogen 34 Cl m M Bakhtiari, M Sadeghi, MK Bakht, H Ghafoori-Fard Physical Review C 87 (3), 034621, 2013 | 8 | 2013 |
| Bremsstrahlung parameters of praseodymium-142 in different human tissues: a dosimetric perspective for 142Pr radionuclide therapy MK Bakht, H Jabal-Ameli, SJ Ahmadi, M Sadeghi, S Sadjadi, C Tenreiro Annals of nuclear medicine 26, 412-418, 2012 | 7 | 2012 |
| Feasibility study of FLUKA Monte Carlo simulation for a beta-emitting brachytherapy source: dosimetric parameters of 142Pr glass seed M Anjomrouz, MK Bakht, M Sadeghi Journal of Radioanalytical and Nuclear Chemistry, 1-7, 2016 | 6 | 2016 |
| Cyclin-like proteins tip regenerative balance in the liver to favour cancer formation BA Fifield, J Talia, C Stoyanovich, MJ Elliott, MK Bakht, A Basilious, ... Carcinogenesis 41 (6), 850-862, 2020 | 5 | 2020 |
Gi Jeong CheonSeoul National University HospitalVerified email at snu.ac.kr
